Epidermal Growth Factor (EGF)-induced Generation of Hydrogen Peroxide
ROLE IN EGF RECEPTOR-MEDIATED TYROSINE PHOSPHORYLATION*

(Received for publication, July 25, 1996, and in revised form, October 2, 1996)

Yun Soo Bae Dagger , Sang Won Kang Dagger , Min Seok Seo Dagger , Ivan C. Baines §, Ephrem Tekle par , P. Boon Chock par and Sue Goo Rhee Dagger **

From the Dagger  Laboratory of Cell Signaling, the § Laboratory of Cell Biology, and the par  Laboratory of Biochemistry, NHLBI, National Institutes of Health, Bethesda, Maryland 20892

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Recent evidence indicates that reactive oxygen species (ROS) may function as intracellular messengers in receptor signaling pathways. The possible role of ROS in epidermal growth factor (EGF) signaling was therefore investigated. Stimulation of A431 human epidermoid carcinoma cells with EGF resulted in a transient increase in the intracellular concentration of ROS, measured with the oxidation-sensitive fluorescent probe 2',7'-dichlorofluorescin diacetate and laser-scanning confocal microscopy. The predominant ROS produced appeared to be H2O2, because the EGF-induced increase in fluorescence was completely abolished by incorporation of catalase into the cells by electroporation. The elimination of H2O2 by catalase also inhibited the EGF-induced tyrosine phosphorylation of various cellular proteins including the EGF receptor and phospholipase C-gamma 1. The dependence of H2O2 production on the intrinsic tyrosine kinase activity of the EGF receptor and the autophosphorylation sites located in its COOH-terminal tail was investigated. EGF failed to induce H2O2 generation in cells expressing a kinase-inactive EGF receptor. However, normal H2O2 generation was observed in cells expressing a mutant receptor from which the 126 COOH-terminal amino acids had been deleted to remove four (out of the total of five) autophosphorylation sites. These results suggest that EGF-induced H2O2 formation requires the kinase activity but probably not the autophosphorylation sites of the EGF receptor and that inhibition of protein tyrosine phosphatase activity by H2O2 may be required for EGF-induced protein tyrosine phosphorylation to be manifested.


INTRODUCTION

Reactive oxygen species (ROS)1 are generally considered cytotoxic, because of the oxidative damage they can cause to cellular components. However, at low concentrations, ROS may function as physiological mediators of cellular responses (1). For example, hydrogen peroxide (H2O2) mimics the stimulatory effects of insulin on glucose transport and lipid synthesis in adipocytes (2, 3). Recently, the production of ROS has been detected in a variety of cells stimulated with cytokines such as transforming growth factor-beta 1 (4, 5), interleukin-1 (6), and tumor necrosis factor-alpha (6, 7), with peptide growth factors such as platelet-derived growth factor (PDGF) (8, 9) and basic fibroblast growth factor (7, 9), with agonists of receptors with seven transmembrane spans such as angiotensin II (10) and lysophosphatidic acid (11) or with phorbol ester (12).

The term ROS encompasses many species including singlet oxygen, the superoxide anion radical (Obardot 2), H2O2, lipid peroxides, nitric oxide, peroxynitrite (ONOO-), the thiyl peroxyl radical (RSOO·), the ferryl radical (FeO2+) and the hydroxyl radical (OH·) (13, 14, 15, 16). However, the chemical nature of ROS generated in response to the activation of various receptors has not been well characterized. H2O2 was shown to be a major component of ROS in cells activated by transforming growth factor-beta 1 or PDGF (4, 8). The generation of ROS in response to various external stimuli has been related to the activation of transcription factors such as NF-kappa B (17) and AP-1 (7, 18), mitogen-activated protein (MAP) kinases (8, 11), and phospholipase A2 (19) to the triggering of apoptosis (20), and to the inhibition of protein tyrosine phosphatases (PTPases) (21, 22). H2O2 is a small, diffusible, and ubiquitous molecule that can be synthesized, as well as destroyed, rapidly in response to external stimuli. As such it fulfills the important prerequisites for an intracellular messengers. We have now investigated the role of ROS in epidermal growth factor (EGF) signal transduction by the EGF receptor (EGFR) protein.


EXPERIMENTAL PROCEDURES

Materials

Bovine catalase was obtained from Boehringer Mannheim; Dulbecco's modified Eagle's medium (DMEM), modified Eagle's medium without phenol red, fetal bovine serum (FBS), penicillin, and streptomycin were from Life Technologies, Inc.; enhanced chemiluminescence (ECL) reagents were from Amersham Corp.; antibodies to phosphotyrosine and the EGFR were from Upstate Biotechnology; antibodies to catalase and alpha -tubulin were from Calbiochem and Oncogene Science, respectively; protein A-Sepharose beads were from Pharmacia Biotech Inc.; and 2',7'-dichlorofluorescin diacetate (DCFH-DA) was from Molecular Probes. A mixture of monoclonal antibodies that was used for immunoprecipitation of phospholipase C-gamma 1 (PLC-gamma 1) was prepared as described (23).

Cell Culture, Electroporation, and Stimulation with EGF

Human A431 epidermoid carcinoma cells were maintained at 37 °C under an atmosphere of 5% CO2 in 150-mm dishes containing DMEM supplemented with 10% FBS. At 80-90% confluency, cells were deprived of serum for 24 h and then harvested by trypsin treatment. Harvested cells were suspended in serum-free DMEM at a density of ~1 × 107 cells/ml, and 100-µl portions of the cell suspension were placed in an electroporation chamber in the absence or the presence of catalase (8 mg/ml). Electroporation was performed by subjecting cells to six pulses, at intervals of 1 or 2 s, at a field strength of 850 ± 50 V/cm and a single-pulse width of 250 µs. Cell viability, assessed by trypan blue exclusion, was typically 70-80% after electroporation under these conditions. The construction, operation, and efficiency of the electroporation apparatus have been described previously (24). The electroporated cells were transferred to DMEM supplemented with 1% FBS and the same concentration of catalase as was present in the electroporation chamber and were placed in an incubator for 18 h.

For analysis of EGF-induced tyrosine phosphorylation, cells were stimulated with EGF (500 ng/ml) for 10 min and then exposed to lysis buffer (20 mM Hepes-NaOH (pH 7.2), 1% Triton X-100, 10% glycerol, 50 mM NaF, 1 mM Na3VO4, leupeptin (5 µg/ml), aprotinin (5 µg/ml), and 1 mM phenylmethylsulfonyl fluoride). The lysates were incubated on ice for 5 min and then centrifuged for 5 min at 10,000 × g. Protein concentration of the supernatant was measured with the Bio-Rad detergent-compatible assay kit and bovine serum albumin as standard.

Immunoprecipitation and Immunoblot Analysis

The lysate supernatants were incubated with monoclonal antibodies to PLC-gamma 1 or to phosphotyrosine for 8 h, after which protein A-Sepharose beads were added, and the incubation was continued for an additional hour. The beads were pelleted at 10,000 × g for 5 min, washed three times with ice-cold lysis buffer, and subjected to SDS-polyacrylamide gel electrophoresis on an 8% gel. The separated proteins were transferred to a nitrocellulose membrane and probed with antibodies to PLC-gamma 1, to phosphotyrosine, or to EGFR. Immune complexes were detected with appropriate secondary antibodies and ECL reagents.

Assay of Intracellular ROS

Intracellular ROS production was measured by the method of Bass et al. (25) as modified for confocal microscopy by Ohba et al. (4). Briefly, dishes of confluent cells at various times after stimulation with EGF were washed with modified Eagle's medium without phenol red and incubated in the dark for 5 min in Krebs-Ringer solution containing 5 mM DCFH-DA. DCFH-DA is a nonpolar compound that readily diffuses into cells, where it is hydrolyzed to the nonfluorescent polar derivative DCFH and thereby trapped within the cells (25). In the presence of a proper oxidant, DCFH is oxidized to the highly fluorescent 2',7'-dichlorofluorescein (DCF). Culture dishes were transferred to a Zeiss Axiovert 135 inverted microscope, equipped with a ×20 Neofluor objective and Zeiss LSM 410 confocal attachment, and ROS generation was detected as a result of the oxidation of DCFH (excitation, 488 nm; emission, 515-540 nm). The effects of DCFH photo-oxidation was minimized by collecting the fluorescent image with a single rapid scan (line average, 4; total scan time, 4.33 s) and identical parameters, such as contrast and brightness, for all samples. The cells were then imaged by differential interference contrast microscopy. Five groups of 20-30 cells each were randomly selected from the image in the digital interserence contrast (DIC) channel for each sample, the fluorescence intensity was then measured for each group from the fluorescence image, and the relative fluorescence intensity was taken as the average of the five values. Therefore, the relative fluorescence intensity (given in arbitrary units) reflects measurements performed on a minimum of 100 cells for each sample. All experiments were repeated at least three times.


RESULTS

Intracellular generation of ROS in A431 cells was measured with DCFH-DA and laser-scanning confocal microscopy. Exposure of quiescent A431 cells to EGF (500 ng/ml) resulted in a rapid increase in DCF fluorescence, with the maximal, 2-fold increase apparent 5 min after stimulation (Fig. 1); fluorescence had returned to the baseline value after 20 min.


Fig. 1. Time course of EGF-induced ROS generation in A431 cells as revealed by DCF fluorescence. A431 cells were cultured in DMEM supplemented with 10% FBS until 80-90% confluency, after which they were incubated overnight in DMEM containing 0.5% FBS. Cells were washed with modified Eagle's medium without phenol red and treated with EGF (500 ng/ml) for the indicated times. ROS generation was measured by DCF fluorescence as described under "Experimental Procedures." Data are representative of three similar experiments, in which the relative fluorescence intensity per cell was calculated by averaging the values for five groups each containing 20-30 cells.
[View Larger Version of this Image (66K GIF file)]


Introduction of catalase, an enzyme that specifically catalyzes the dismutation of H2O2 to O2 and H2O into A431 cells by electroporation, prevented EGF-induced DCFH oxidation (Fig. 2), suggesting that the latter is mainly mediated by H2O2. The amount of catalase incorporated into cells was about five times that of the endogenous enzyme (see below). The introduction of catalase also reduced DCFH oxidation in cells not exposed to EGF.


Fig. 2. Effect of catalase incorporated into cells by electroporation on EGF-induced ROS generation. A431 cells that had been subjected to electroporation in the absence or the presence of catalase (8 mg/ml) were incubated in the absence or the presence of EGF (500 ng/ml) for 5 min, after which the generation of ROS was measured. Data are representative of three similar experiments.
[View Larger Version of this Image (64K GIF file)]


We next assessed the effect of incorporated catalase on EGF-induced tyrosine phosphorylation. EGF induced a rapid increase in tyrosine phosphorylation of several proteins in control cells as revealed by immunoblot analysis of cell lysates with antibodies to phosphotyrosine (Fig. 3A). Increased tyrosine phosphorylation of a broad band with an apparent molecular mass of ~160 kDa that was recognized by antibody to the EGFR was particularly prominent. However, in cells containing exogenous catalase, EGF had no apparent effect on tyrosine phosphorylation of the EGFR or other proteins. Phosphorylation of PLC-gamma 1, a well characterized target of the EGFR kinase, was studied further. Immunoblot analysis, with antibodies to PLC-gamma 1, of PLC-gamma 1 immunoprecipitated from control cells treated with EGF revealed a broad immunoreactive band (Fig. 3B); the increased breadth of the band relative to that apparent with unstimulated cell is indicative of increased tyrosine phosphorylation (26). The effect of catalase was investigated by subjecting PLC-gamma 1 immunoprecipitated with antibodies to PLC-gamma 1 to immunoblot analysis with antibody to phosphotyrosine (Fig. 3C). Tyrosine phosphorylation of PLC-gamma 1 was apparent from control EGF-treated cells but not with that from EGF-treated cells containing exogenous catalase. As demonstrated previously (26, 27), coprecipitation of autophosphorylated EGFR with tyrosine-phosphorylated PLC-gamma 1 was observed. The requirement for H2O2 of the tyrosine phosphorylation of PLC-gamma 1 was also demonstrated by precipitating proteins with antibody to phosphotyrosine and immunoblot analysis with antibodies to PLC-gamma 1 (Fig. 3D).


Fig. 3. Effect of exogenous catalase on EGF-induced protein tyrosine phosphorylation. A431 cells that had been electroporated in the absence or the presence of catalase were incubated for 10 min in the absence or the presence of EGF (500 ng/ml), after which cell lysates were prepared. A, lysates were subjected to immunoblot analysis with antibody to phosphotyrosine. The positions of prestained molecular size markers (in kilodaltons) are indicated on the right and that of the EGFR on the left. B and C, lysates were subjected to immunoprecipitation (IP) with monoclonal antibodies to PLC-gamma 1 (alpha PLCgamma 1), and the immunoprecipitates were subjected to immunoblot analysis with the same PLC-gamma 1-specific antibodies (B) or with antibodies to phosphotyrosine (alpha PY) (C). D, lysates were subjected to immunoprecipitation with antibodies to phosphotyrosine, and the immunoprecipitates were subjected to immunoblot analysis with antibodies to PLC-gamma 1. E, lysates were subjected to immunoblot analysis with antibodies to catalase. F, lysates were subjected to immunoblot analysis with antibodies to alpha -tubulin.
[View Larger Version of this Image (33K GIF file)]


Because the exogenous bovine catalase and endogenous human catalase can be separated on a SDS-polyacrylamide gel (Fig. 3E), the amount of exogenous catalase incorporated to cells was estimated from immunoblot analysis to be approximately five times the amount of endogenous enzyme. Equal application of lysate protein among gel lanes for all immunoblot experiments was confirmed by immunoblot analysis with antibodies to alpha -tubulin (Fig. 3F).

To test whether the number of EGFR on the cell surface is affected by electroporation or by the addition of catalase concurrent with electroporation, we measured the number of EGFR using 125I-EGF. The binding of 125I-EGF was saturable and inhibited in a concentration-dependent manner by the addition of unlabeled EGF (figure not shown). The calculated binding site densities per cell were 4 × 106, 6 × 106, and 5 × 106, respectively, for control cells, electroporated cells assessed after 18 h of recovery, and cells electroporated in the presence of catalase and assessed after 18 h of recovery, suggesting that receptor number is not affected by the treatments. We also found that the autophosphorylation activity of immunoprecipitated EGFR is not affected by the presence of catalase (8 mg/ml) or H2O2 (1 mM) (data not shown). These results suggest that the inhibition of EGF-induced tyrosine phosphorylation in cells electroporated in the presence of catalase is not attributable to either the reduction in EGFR number, the inhibition of EGFR kinase by catalase, or the requirement of H2O2 for the activation of EGFR kinase.

To assess the role of the intrinsic kinase activity and autophosphorylation sites of the EGFR in the EGF-induced generation of H2O2, we studied cell lines that express either the wild-type EGFR, a tyrosine kinase-negative EGFR in which Lys721 is replaced with Met, or a truncated EGFR (CD-126) lacking the COOH-terminal 126 amino acids (and therefore the four tyrosine phosphorylation sites at positions 1173, 1148, 1086, and 1068). These cell lines were generated previously by Margolis et al. (28, 29) by expression of human EGFR cDNAs in NIH 3T3 cells that lack endogenous EGFR (2.2 cells). Receptor density was 3 × 105, 3 × 105, 1.5 × 105 receptors/cell, respectively, for cells expressing wild-type, kinase-negative, and CD-126 mutant EGFR (30, 31). Treatment with EGF increased the concentration of H2O2 in cells expressing the wild-type or CD-126 mutant EGFR but not in the cells expressing the catalytically inactive mutant (Fig. 4). These results suggest that the intrinsic tyrosine kinase activity, but not the four autophosphorylation sites, is essential for the EGF-induced H2O2 generation.


Fig. 4. Effects of EGF on H2O2 generation in NIH 3T3 2.2 cells expressing wild-type, kinase-defective, or a COOH-terminal deletion mutant (CD-126) EGFR. A, DCF fluorescence was measured with a confocal laser-scanning microscope after incubation of NIH 3T3 2.2 cells expressing wild-type, kinase-defective, or CD-126 mutant EGFR in the presence of EGF (500 ng/ml) for 5 min; Control represents cells expressing wild-type EGFR incubated in the absence of EGF. Cells expressing mutant receptors yielded similar basal DCF fluorescence in the absence of EGF. B, from the images shown in A, relative fluorescence intensity per cell was calculated by averaging the values for five groups each containing 20-30 cells. Data are representative of three similar experiments.
[View Larger Version of this Image (52K GIF file)]



DISCUSSION

Extracellular release of ROS is a well characterized response of phagocytic cells to a variety of agonists. However, recent observations indicate that nonphagocytic cells also generate ROS (4, 5, 6, 7, 8, 9, 10, 11, 12). To identify the ROS responsible for the intracellular oxidation of DCFH, Ohba et al. (4) added catalase to the culture medium of osteoblastic cells. The addition of catalase completely inhibited the transforming growth factor-beta 1-induced increase in DCF fluorescence, suggesting that H2O2 was important in DCFH oxidation in response to transforming growth factor-beta 1. Because the cells are not permeable to catalase, the researchers proposed that H2O2 was released into the medium from the plasma membrane, the site of its production, and then diffused into the cells. Whether this diffusion was promoted by the trapped DCFH is not clear. Catalase was also used to characterize the ROS generated in PDGF-treated rat vascular smooth muscle cells (8). Unlike most other cells, these muscle cells incorporated, by an unknown mechanism, catalase that was added to the culture medium. Catalase incorporation completely blocked the PDGF-stimulated increase in H2O2 production, suggesting that H2O2 is also the predominant ROS induced by PDGF in these cells.

We have now shown that EGF induces ROS production in A431 cells and that the increase in DCF fluorescence was primarily attributable to H2O2 on the basis of its sensitivity to catalase introduced into the cells by electroporation. With incorporation of catalase by electroporation, no ambiguity arises as to whether H2O2 is released first into the medium and is then taken up by the cells. Unlike rat vascular smooth muscle cells, the simple addition of catalase to the culture medium did not result in uptake of the enzyme and a consequent decrease in DCF fluorescence (data not shown). The incorporation of catalase also reduced DCFH oxidation in A431 cells not exposed to EGF, indicating that substantial amounts of H2O2 are generated in the absence of EGF, probably as a result of respiratory activity and the presence of various growth factors in 1% FBS. Overnight incubation of electroporated cells in medium containing 1% FBS was necessary for cells to recover from the electroporation procedure and to exhibit a tyrosine phosphorylation response to EGF. A high background of DCF fluorescence was apparent even in cells containing exogenous catalase. Whether this background DCFH oxidation is caused by residual H2O2 not degraded by catalase, by cellular oxidants other than H2O2, or by oxidants introduced by the experimental procedure (for example, by photo-oxidation) is not clear. Therefore, we took great care to manipulate the cells under identical conditions, with the exception of the indicated additions.

The EGF-induced tyrosine phosphorylation of various cellular proteins was completely blocked in A431 cells containing exogenous catalase. Furthermore, detailed experiments with PLC-gamma 1 indicated that its tyrosine phosphorylation in response to EGF requires the EGF-induced increase in H2O2 concentration. Because tyrosine phosphorylation is essential for the activation of PLC-gamma 1 in growth factor-treated cells (32), an increase in H2O2 would appear to be required for growth factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate. Treatment of smooth muscle cells with H2O2 was previously shown to release Ca2+ from intracellular stores that are sensitive to inositol 1,4,5-trisphosphate (33). We also observed a rapid increase in intracellular Ca2+ following addition of 1 mM H2O2 to A431 cells in a Ca2+-free medium (figure not shown). These observations are consistent with the notion that H2O2 inhibits PTPases and thereby causes activation (tyrosine phosphorylation) of PLC-gamma 1 (see below).

Our study with EGF, together with previous studies with basic fibroblast growth factor (7, 9) and PDGF (8, 9), suggests that the generation of H2O2 is a common signaling event for peptide growth factors. However, the role of H2O2 in growth factor signaling is not clear. Exogenously added H2O2 was previously shown to elicit tyrosine phosphorylation in several cell types (34, 35), whereas inhibition of the PDGF-induced increase in H2O2 blocked various steps in signaling by this growth factor, including tyrosine phosphorylation of MAP kinase (8). Furthermore, H2O2 directly inhibits PTPase activity in vitro, and this inhibition is completely reversed by incubation with dithiothreitol (21). All PTPases contain one essential sulfhydryl group at their active site that is susceptible to oxidation because of its unusually low pKa (<5) (36). These observations suggest that PTPases may be targets of intracellularly generated H2O2. Inactivation of PTPases would result in increased tyrosine phosphorylation. Furthermore, the specific activities of PTPases in vitro are 10-1000 times those of protein tyrosine kinases (37). Therefore, in most cells, the activation of a receptor tyrosine kinase by the binding of a growth factor may not be sufficient to increase the steady-state level of protein tyrosine phosphorylation; concurrent inhibition of PTPases might be necessary, and this inhibition may be achieved through H2O2.

Binding of various peptide growth factors to their cognate receptors activates multiple signaling pathways, including those mediated by PLC-gamma 1, phosphatidylinositol 3-kinase, signal transducer and activator of transcription protein (STAT), and MAP kinase (38, 39). The ligand-bound receptors dimerize and transphosphorylate each other at several tyrosine residues, thereby creating binding sites for cellular proteins that contain Src homology 2 (SH2) domains, including PLC-gamma 1, GTPase-activating protein of RAS, the 85-kDa subunit of phosphatidylinositol 3-kinase (p85), and SH2-containing collagen protein. Studies with autophosphorylation site mutants of the receptors for PDGF (40), colony-stimulating factor (41), fibroblast growth factor (42), and nerve growth factor (43) have shown that elimination of specific individual sites selectively abrogates the association of one or two SH2-containing proteins with the receptors, suggesting that individual autophosphorylation sites mediate the binding of specific SH2-containing protein. However, the association of PLC-gamma 1, GTPase-activating protein, p85, or SH2-containing collagen protein with the EGFR, which contains five autophosphorylation sites (residues 992, 1068, 1086, 1148, and 1173) in the COOH-terminal region, does not appear to stringently require individual autophosphorylation sites, but decreases gradually as the sites are removed one by one by COOH-terminal truncation (44).

The intrinsic tyrosine kinase activity and autophosphorylation sites of the EGFR are not required for all signaling pathways activated by EGF. The activation of MAP kinase can occur independently of EGFR kinase activity (45, 46), and the activation of signal transducer and activator of transcription proteins requires none of the autophosphorylation sites (47). Our data with the kinase-inactive mutant indicate that EGFR-dependent H2O2 generation requires the intrinsic kinase activity of the receptor. The CD-126 mutant receptor, which lacks four of the five autophosphorylation sites, was as effective as the wild-type receptor in inducing H2O2 generation, suggesting that the tyrosine phosphorylation sites of the EGFR are not required for this effect. However, the possibility that the remaining autophosphorylation site (Tyr992) in CD-126 specifically serves as the binding site for a signaling molecule that mediates H2O2 generation cannot be excluded.

The mechanism by which H2O2 is generated has been studied extensively in neutrophils and macrophages (48). In these phagocytic cells, Obardot 2 is first produced from the reduction of O2 by a multicomponent NADPH oxidase system, which consists of a membrane-bound cytochrome b, a 22-kDa subunit (p22-phox), and a 90-110-kDa glycoprotein subunit (gp91-phox). In addition to these membrane-bound components, NADPH oxidase activity requires various cytosolic factors including SH3-containing proteins (p47-phox and p67-phox) and the small GTP-binding protein Rac.

The mechanism of Obardot 2 and H2O2 generation in nonphagocytic cells is unknown. Neither the xanthine oxidase system nor the mitochondrial respiratory chain appears to mediate receptor-triggered ROS generation (6). Evidence suggests involvement of an NADPH oxidase-like system, which might be linked to p22-phox, p47-phox, and p67-phox proteins, in fibroblast cells (6, 7, 9, 10, 49). However, the cytochrome b in fibroblasts appears to be structurally and genetically distinct from that in phagocytic cells (50). The mechanism by which this cytochrome b might be modulated by the kinase activity of the EGFR requires further investigation.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   Present Address: Dept. of Extramural Affairs, NHLBI, NIH Bethesda, MD 20892.
**   To whom correspondence should be addressed: NIH, Bldg. 3, Rm. 122, 3 Center Dr. MSC 0320, Bethesda, MD 20892-0320. Tel.: 301-496-9646; Fax: 301-496-0599.
1    The abbreviations used are: ROS, reactive oxygen species; PDGF, platelet-derived growth factor; EGF, epidermal growth factor; EGFR, EGF receptor; PTPase, protein tyrosine phosphatase; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; DCFH-DA, 2',7'-dichlorofluorescin diacetate; DCF, 2',7'-dichlorofluorescein; SH, Src homology; MAP, mitogen-activated protein; PLC-gamma 1, phospholipase C-gamma 1.

Acknowledgments

We thank Drs. J. Schlessinger and I. Lax for the NIH 3T3 2.2 cell lines expressing the wild-type, kinase-negative, and CD-126 EGFR proteins.


REFERENCES

  1. Schreck, R., and Baeuerle, P. A. (1991) Trends Cell Biol. 1, 39-42 [CrossRef]
  2. Mukherjee, S. P., Lane, R. H., and Lynn, W. S. (1978) Biochem. Pharmacol. 27, 2589-2594 [Medline] [Order article via Infotrieve]
  3. May, J. M., and de Haen, C. (1979) J. Biol. Chem. 254, 9017-9021 [Abstract]
  4. Ohba, M., Shibanuma, M., Kuroki, K., and Nose, K. (1994) J. Cell Biol. 126, 1079-1088 [Abstract]
  5. Thannickal, V. J., and Fanburg, B. L. (1995) J. Biol. Chem. 270, 30334-30338 [Abstract/Free Full Text]
  6. Meier, B., Radeke, H. H., Selle, S., Younes, M., Sies, H., Resch, K., and Habermehl, G. G. (1989) Biochem J. 263, 539-545 [Medline] [Order article via Infotrieve]
  7. Lo, Y. Y. C., and Cruz, T. F. (1995) J. Biol. Chem. 270, 11727-11730 [Abstract/Free Full Text]
  8. Sundaresan, M., Yu, Z.-X., Ferrans, V., Irani, K., and Finkel, T. (1995) Science 270, 296-299 [Abstract]
  9. Krieger-Brauer, H. I., and Kather, H. (1995) Biochem J. 307, 549-556 [Medline] [Order article via Infotrieve]
  10. Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., and Alexander, R. W. (1994) Circ. Res. 74, 1141-1148 [Abstract]
  11. Chen, Q., Olashaw, N., and Wu, J. (1995) J. Biol. Chem. 270, 28499-28502 [Abstract/Free Full Text]
  12. Robertson, F. M., Beavis, A. J., Oberyszyn, T. M., O'Conell, S. M., Dokidos, A., Laskin, D. L., Laskin, J. D., and Reiners, J. J., Jr. (1990) Cancer Res. 50, 6062-6067 [Abstract]
  13. Moncada, S., Palmer, R. M., and Higgs, E. A. (1991) Pharmacol. Rev. 43, 109-142 [Medline] [Order article via Infotrieve]
  14. Huie, R. E., and Padmaja, S. (1993) Free Radical Res. Commun. 18, 195-199 [Medline] [Order article via Infotrieve]
  15. Yim, M. B., Chae, H. Z., Rhee, S. G., Chock, P. B., and Stadtman, E. R. (1994) J. Biol. Chem. 269, 1621-1626 [Abstract/Free Full Text]
  16. Stadtman, E. R., and Oliver, C. N. (1991) J. Biol. Chem. 266, 2005-2008 [Free Full Text]
  17. Schreck, R., Rieber, P., and Baeuerle, P. A. (1991) EMBO J. 10, 2247-2258 [Abstract]
  18. Pahl, H. L., and Baeuerle, P. A. (1994) Bioessays 16, 497-501 [Medline] [Order article via Infotrieve]
  19. Zor, U., Ferber, E., Gergely, P., Szücs, K., Dombradi, V., and Goldman, R. (1993) Biochem. J. 295, 879-888 [Medline] [Order article via Infotrieve]
  20. Jacobson, M. (1996) Trends Biochem. Sci. 21, 83-86 [CrossRef][Medline] [Order article via Infotrieve]
  21. Hecht, D., and Zick, Y. (1992) Biochem. Biophys. Res. Commun. 188, 773-779 [Medline] [Order article via Infotrieve]
  22. Sullivan, S. G., Chiu, D. T.-Y., Errasfa, M., Wang, J. M., Qi, J.-S., and Stern, A. (1994) Free Radical Biol. & Med. 16, 399-403 [CrossRef][Medline] [Order article via Infotrieve]
  23. Suh, P.-G., Ryu, S. H., Choi, W. C., Lee, K.-Y., and Rhee, S. G. (1988) J. Biol. Chem. 263, 14497-14504 [Abstract/Free Full Text]
  24. Tekle, E., Astumian, R. D., and Chock, P. B. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4230-4234 [Abstract]
  25. Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C., and Thomas, M. (1983) J. Immunol. 130, 1910-1917 [Abstract/Free Full Text]
  26. Margolis, B., Rhee, S. G., Felder, S., Mervic, M., Lyall, R., Levitzki, A., Ullrich, A., Zilberstein, A., and Schlessinger, J. (1989) Cell 57, 1101-1107 [Medline] [Order article via Infotrieve]
  27. Wahl, M. I., Nishibe, S., Suh, P.-G., Rhee, S. G., and Carpenter, G. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 1568-1572 [Abstract]
  28. Margolis, B., Bellot, A., Honegger, A., Ullrich, A., Schlessinger, J., and Zilberstein, A. (1990) Mol. Cell. Biol. 10, 435-441 [Medline] [Order article via Infotrieve]
  29. Margolis, B. L., Lax, I., Kris, R., Dombalagian, M., Honegger, A. M., Howk, R., Givol, D., Ullrich, A., and Schlessinger, J. (1989) J. Biol. Chem. 264, 10667-10671 [Abstract/Free Full Text]
  30. Honegger, A. M., Dull, T. J., Felder, S., Van Obberghen, E., Bellot, F., Szapary, D., Schmidt, A., Ullrich, A., and Schlessinger, J. (1987) Cell 51, 199-209 [Medline] [Order article via Infotrieve]
  31. Batzer, A. G., Rotin, D., Ureña, J. M., Skolnik, E. Y., and Schlessinger, J. (1994) Mol. Cell. Biol. 14, 5192-5201 [Abstract]
  32. Kim, H. K., Kim, J. W., Zilberstein, A., Margolis, B., Kim, J. G., Schlessinger, J., and Rhee, S. G. (1991) Cell 65, 435-441 [Medline] [Order article via Infotrieve]
  33. Roverti, A., Coassin, M., Maiorino, M., Zamburlini, A., van Amsterdam, F. T. M., ratti, E., and Ursini, F. (1992) Arch. Biochem. Biophys. 297, 265-270 [Medline] [Order article via Infotrieve]
  34. Gamou, S., and Shimizu, N. (1995) FEBS Lett. 357, 161-164 [CrossRef][Medline] [Order article via Infotrieve]
  35. Heffetz, D., Bushkin, I., Dror, R., and Zick, Y. (1990) J. Biol. Chem. 265, 2896-2902 [Abstract/Free Full Text]
  36. Stone, R. L., and Dixon, J. E. (1994) J. Biol. Chem. 269, 31323-31326 [Free Full Text]
  37. Fischer, E. H., Charbonneau, H., and Tonks, N. K. (1991) Science 253, 401-406 [Medline] [Order article via Infotrieve]
  38. Ullrich, A., and Schlessinger, J. (1990) Cell 61, 203-212 [Medline] [Order article via Infotrieve]
  39. Hunter, T. (1995) Cell 80, 225-236 [Medline] [Order article via Infotrieve]
  40. Claesson-Welsh, L. (1994) J. Biol. Chem. 269, 32023-32026 [Free Full Text]
  41. Reedijk, M., Liu, X., van der Geer, P., Letwin, K., Waterfield, M. D., Hunter, T., and Pawson, T. (1992) EMBO J. 11, 1365-1372 [Abstract]
  42. Mohammadi, M., Dionne, C. A., Li, W., Li, N., Spivak, T., Honegger, A. M., Jaye, M., and Schlessinger, J. (1992) Nature 358, 681-684 [CrossRef][Medline] [Order article via Infotrieve]
  43. Obermeier, A., Lammers, R., Wiesmüller, K.-H., Jung, G., Schlessinger, J., and Ullrich, A. (1993) J. Biol. Chem. 268, 22963-22966 [Abstract/Free Full Text]
  44. Soler, C., Beguinot, L., and Carpenter, G. (1994) J. Biol. Chem. 269, 12320-12324 [Abstract/Free Full Text]
  45. Campos-González, R., and Glenney, J. R., Jr. (1992) J. Biol. Chem. 267, 14535-14538 [Abstract/Free Full Text]
  46. Selva, E., Raden, D. L., and Davis, R. J. (1993) J. Biol. Chem. 268, 2250-2254 [Abstract/Free Full Text]
  47. David, M., Wong, L., Flavell, R., Thomson, S. A., Wells, A., Larner, A. C., and Johnson, G. R. (1996) J. Biol. Chem. 271, 9185-9188 [Abstract/Free Full Text]
  48. Thelen, M., Dewald, B., and Baggiolini, M. (1993) Physiol. Rev. 73, 797-821 [Free Full Text]
  49. Jones, S. A., Wood, J. D., Coffey, M. J., and Jones, O. T. G. (1994) FEBS Lett. 355, 178-182 [CrossRef][Medline] [Order article via Infotrieve]
  50. Meier, B., Jesaitis, A., Emmendörffer, A., Roesler, J., and Quinn, M. T. (1993) Biochem. J. 289, 481-486 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.